NEW YORK (GenomeWeb News) – Roche Diagnostics and the US President's Emergency Plan for AIDS Relief (PEPFAR) announced on Tuesday a public-private partnership aimed at improving the capabilities of laboratories in Africa in the area of HIV/AIDS training and knowledge.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.